Mannkind (MNKD) Asset Utilization Ratio (2011 - 2026)

Mannkind (MNKD) reported Asset Utilization Ratio of 0.47 for Q1 2026, down 36.57% year-over-year from 0.74 in Q1 2025, and down 13.42% quarter-over-quarter from 0.54 in Q4 2025.

Mannkind (MNKD) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Mannkind (MNKD) has 14 years of Asset Utilization Ratio data on file, last reported at 0.47 in Q1 2026.

  • Asset Utilization Ratio for Q1 2026 came in at 0.47, down 36.57% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.47 (down 36.57% YoY), and the FY2025 annual result was 0.59, down 10.44% from the prior year.
  • Asset Utilization Ratio declined to 0.47 in Q1 2026 per MNKD's latest filing, from 0.54 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.74 in Q1 2025 and troughed at 0.16 in Q2 2022.
  • A 5-year average of 0.48 and a median of 0.52 in 2023 frame the typical range for Asset Utilization Ratio.
  • The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio sank 40.0% in 2022, then jumped 226.71% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.28 in 2022, then soared by 81.51% to 0.5 in 2023, then surged by 33.04% to 0.67 in 2024, then fell by 18.5% to 0.54 in 2025, then retreated by 13.42% to 0.47 in 2026.
  • Business Quant data shows MNKD's Asset Utilization Ratio at 0.47 in Q1 2026, 0.54 in Q4 2025, and 0.69 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn 0.47

Historic Data

Download Data
DateValue
Mar 31, 2026 0.47
Dec 31, 2025 0.54
Sep 30, 2025 0.69
Jun 30, 2025 0.73
Mar 31, 2025 0.74
Dec 31, 2024 0.67
Sep 30, 2024 0.59
Jun 30, 2024 0.54
Mar 31, 2024 0.47
Dec 31, 2023 0.50
Sep 30, 2023 0.56
Jun 30, 2023 0.52
Mar 31, 2023 0.37
Dec 31, 2022 0.28
Sep 30, 2022 0.20
Jun 30, 2022 0.16
Mar 31, 2022 0.22
Dec 31, 2021 0.27
Sep 30, 2021 0.33
Jun 30, 2021 0.26